In Brief: Gen-Probe/MicroProbe litigation
This article was originally published in The Gray Sheet
Executive Summary
Gen-Probe/MicroProbe litigation: As part of a settlement of a 1993 patent infringement suit filed by Gen-Probe ("The Gray Sheet" May 24, 1994, I&W-4), Microprobe agrees that two Gen-Probe nucleic acid probe patents are valid and are infringed by the firm's Affirm product line. MicroProbe also consents to an injunction against further infringement...
You may also be interested in...
Drug Shortages, Inspections In Focus At US FDA Appropriations Hearing
Commissioner Robert Califf discussed the agency’s request for $12.3m to address shortages and legislation to require that manufacturers provide more detailed information about increased demand and supply chain vulnerabilities.
Parkinson’s Results Further Sweeten AbbVie’s Acquisition of Cerevel
Cerevel, which AbbVie is spending $8.7bn to acquire, unveiled topline results from the TEMPO-3 study of tavapadon, which an analyst said represents potentially a $1bn opportunity.
FDA’s New Dataset Aims To Assist Labs In Assessing Medical Device Biocompatibility
The US FDA’s device center has unveiled a new public dataset designed to assist chemistry laboratories in ensuring the robustness of chemical characterization methods used to assess the biocompatibility of medical devices.